期刊文献+

顺铂对大鼠红细胞生成素产生的影响 被引量:3

Effect of cis-Diamine-dichloro-platinum(DDP)on Erythropoietin in Rats
下载PDF
导出
摘要 目的 探讨顺铂 (DDP)对大鼠肾脏红细胞生成素 (Epo)产生、分泌的影响及与贫血的关系。 方法 经尾静脉注射DDP (8mg/kg)诱发大鼠贫血 ,采用胎肝细胞3 H TdR掺入法检测大鼠血清Epo的含量 ,并同时观察了大鼠肾组织在光镜及电镜下形态的改变。结果 在DDP诱发大鼠贫血过程中 ,血清Epo升高的幅度较小 ,血红蛋白 (Hb)降低持续的时间较长 ,血清尿素氮 (BUN)显著升高 ,病理切片证实DDP可引起大鼠明显的肾损伤。结论 DDP可抑制大鼠Epo的产生 ,Epo的缺乏是导致大鼠贫血的主要原因之一。 Objective To investigate effects of cis diamine dichloro platinum(DDP)on the production of serum erythropoietin(Epo) and secretion by the kidney and its association with anemia.Methods Anemia was induced in SD rats by DDP( 8 mg/kg ).Serum Epo levels were measured by 3 H TdR in fetal hepatocytes.Changes of renal tissue were observed by light microscope and electron microscope.Results The elevation of serum Epo was rather low.Lowering of hemoglobin concentration sustained a longer time in DDP induced anemia.Serum urea nitrogen elevated significantly.Pathological findings revealed that DDP might significantly cause renal damage in rats. Conclusions DDP might inhibit Epo production,which might be the main cause of anemia.
出处 《工业卫生与职业病》 CAS CSCD 北大核心 2002年第4期206-209,共4页 Industrial Health and Occupational Diseases
关键词 红细胞生成素 顺铂 贫血 肾毒性 药物副作用 cis Diamine dichloro platinum Anemia Erythropoietin Nephrotoxicity
  • 相关文献

同被引文献13

  • 1李承慧,胡冰.肺癌NP方案化疗后Hb下降相关因素的探讨[J].现代肿瘤医学,2007,15(6):787-789. 被引量:1
  • 2Wood PA, Hrushesky WJ. Cisplatin -associated anemia: an erythropoietin deficiency syndrome[J]. J Clin Invest, 1995,95 (4): 1650 - 1659.
  • 3Schuster SJ, Koury ST, Bohrer M,et al. Cellular sites of extrarenal and renal erythropoietin production in anaemic rats [ J ]. Br J Haematol, 1992,81 (2) :153 - 159.
  • 4Leibbrandt ME, Wolfgang GH, Metz AL,et al. Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells [ J ]. Kidney Int, 1995,48 ( 3 ) :761 - 770.
  • 5Smith DH, Goldwasser E, Vokes EE. Serum immunoerythropoietin levels in patients with cancer receiving cisplatin - based chemotherapy[J]. Cancer,1991,68(5) :1101 - 1105.
  • 6Belenkov AI, Shenouda G, Rizhevskaya E, et al . Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin[J]. Mol Cancer Ther,2004,3(12) :1525 - 1532.
  • 7Grote T, Yeilding AL, Castillo R, et al. Efficacy and safety analysis of epoetin alfa in patients with small - cell lung cancer: a randomized, double - blind, placebo - controlled trial[J]. J Clin Oncol, 2005,23 (36) :9377 - 9386.
  • 8Leyland -Jones B, Semiglazov V, Pawlicki M, et al . Maintaining normal epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first - line chemotherapy: a survival study[J]. J Clin Oncol,2005,23 ( 25 ) :5960 - 5972.
  • 9Henke M, Laszig R, Rube C,et al . Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double - blind, placebo - controlled trial[ J ]. Lancet,2003,362(9392) : 1255 - 1260.
  • 10Ludwig H, Van Belle S, Barrett - Lee P, et al . The European Cancer Anaemia Survey (ECAS) : a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients[J]. Eur J Cancer,2004 ,40(15) : 2293 ~ 2306.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部